344 related articles for article (PubMed ID: 27163153)
1. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
[TBL] [Abstract][Full Text] [Related]
2. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
[TBL] [Abstract][Full Text] [Related]
3. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
[TBL] [Abstract][Full Text] [Related]
4. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study.
Kang S; Kang WD; Chung HH; Jeong DH; Seo SS; Lee JM; Lee JK; Kim JW; Kim SM; Park SY; Kim KT
J Clin Oncol; 2012 Apr; 30(12):1329-34. PubMed ID: 22412131
[TBL] [Abstract][Full Text] [Related]
5. Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis?
Gülseren V; Kocaer M; Özdemir İA; Çakır İ; Sancı M; Güngördük K
Curr Probl Cancer; 2020 Feb; 44(1):100498. PubMed ID: 31395281
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
[TBL] [Abstract][Full Text] [Related]
7. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
[TBL] [Abstract][Full Text] [Related]
8. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
[TBL] [Abstract][Full Text] [Related]
9. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of serum CA125 levels with ER, PR, P53 and Ki-67 expression in endometrial carcinomas.
Budak E; Solakoglu Kahraman D; Budak A; Yanarateş A; Inan AH; Kanmaz AG; Beyan E
Ginekol Pol; 2019; 90(12):675-683. PubMed ID: 31909459
[TBL] [Abstract][Full Text] [Related]
11. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
[TBL] [Abstract][Full Text] [Related]
13. Nodal infiltration in endometrial cancer: a prediction model using best subset regression.
Matsumoto YK; Himoto Y; Nishio M; Kikkawa N; Otani S; Ito K; Yamanoi K; Kato T; Fujimoto K; Kurata Y; Moribata Y; Yoshida H; Minamiguchi S; Mandai M; Kido A; Nakamoto Y
Eur Radiol; 2024 May; 34(5):3375-3384. PubMed ID: 37882835
[TBL] [Abstract][Full Text] [Related]
14. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.
Kang S; Thompson Z; McClung EC; Abdallah R; Lee JK; Gonzalez-Bosquet J; Wenham RM; Chon HS
Int J Gynecol Cancer; 2018 Feb; 28(2):260-266. PubMed ID: 29194195
[TBL] [Abstract][Full Text] [Related]
16. A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.
Zhao LY; Yin Y; Li X; Zhu CJ; Wang YG; Chen XL; Zhang WH; Chen XZ; Yang K; Liu K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Sep; 7(37):59630-59639. PubMed ID: 27449100
[TBL] [Abstract][Full Text] [Related]
17. Discordance between serum level and tissue immunohistochemical staining of CA125 in endometrioid adenocarcinoma of the uterine corpus.
Yamazawa K; Hirashiki K; Usui H; Mitsuhashi A; Matsui H; Sekiya S
Int J Gynecol Pathol; 2005 Jul; 24(3):254-9. PubMed ID: 15968201
[TBL] [Abstract][Full Text] [Related]
18. A patient group at negligible risk of para-aortic lymph node metastasis in endometrial cancer.
Todo Y; Okamoto K; Takeshita S; Sudo S; Kato H
Gynecol Oncol; 2016 Apr; 141(1):155-9. PubMed ID: 26825615
[TBL] [Abstract][Full Text] [Related]
19. Risk-stratification of endometrial carcinomas revisited: a combined preoperative and intraoperative scoring system for a reliable prediction of an advanced disease.
Tuomi T; Pasanen A; Luomaranta A; Leminen A; Bützow R; Loukovaara M
Gynecol Oncol; 2015 Apr; 137(1):23-7. PubMed ID: 25643690
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma.
Suh DH; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Obstet Gynecol Reprod Biol; 2012 Jun; 162(2):206-10. PubMed ID: 22445206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
